Market Executive Summary

Single cell multiomics technologies typically measure multiple types of molecules from the same individual cell, allowing for more in-depth biological insight than can be gained by analyzing each molecular layer from separate cells. Single-cell multimodal omics (scMulti-omics) technologies allow for the measurement of multiple modalities from the same cell, including DNA methylation, chromatin accessibility, RNA expression, protein abundance, gene perturbation, and spatial information, unlike live-cell fluorescence imaging, which involves the destruction of cells for analysis.

The global market for Single Cell Multiomics was estimated to be worth US$ 1684 million in 2023 and is forecast to a readjusted size of US$ 3085.1 million by 2030 with a CAGR of 8.5% during the forecast period 2024-2030.

Single cell multiomics technologies typically measure multiple types of molecules from the same individual cell, allowing for more in-depth biological insight than can be gained by analyzing each molecular layer from separate cells. Single-cell multimodal omics (scMulti-omics) technologies allow for the measurement of multiple modalities from the same cell, including DNA methylation, chromatin accessibility, RNA expression, protein abundance, gene perturbation, and spatial information, unlike live-cell fluorescence imaging, which involves the destruction of cells for analysis.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Single Cell Multiomics, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Single Cell Multiomics by region & country, by Type, and by Application.

The Single Cell Multiomics market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Single Cell Multiomics.

Global Single Cell Multiomics Companies Covered

10x Genomics, Becton, Dickinson and Company, Berkeley Lights, BGI Genomics, Bio Rad Laboratories, Danaher Corporation (Cytiva Life Sciences), Dolomite Bio, Epicypher, Fluidigm Corporation, Illimina, Miltenyi Biotec B.V. & CO., Mission Bio, Nanostring Technologies, Olink Holding AB (Olink Proteomics), Parse Bioscience, Qiagen N.V., Takara Holdings Inc. Takara Bio Group, Thermo Fisher Scientific

Global Single Cell Multiomics Market, by Region

North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

Global Single Cell Multiomics Market, Segment by Type

Single cell genomics

Single cell proteomics

Single cell transcriptomics

Single cell metabolomics

Global Single Cell Multiomics Market, Segment by Application

Oncology

Cell biology

Neurology

Immunology

Stem cell research

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Single Cell Multiomics manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Single Cell Multiomics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Single Cell Multiomics in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.